Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 17 May 2024 for Gritstone bio, Inc..
Filing timeline
BuySaleKarin Jooss
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Karin Jooss: trading record in brief
Filings by Karin Jooss span 2 companies, the busiest being Gritstone bio, Inc. and Fate Therapeutics Inc. Over a trading history stretching from 7 January 2021 to 16 May 2024, the count stands at 9 filings.
On the market, this insider has only sold: 2 sales, €41k in total. Other entries cover 7 share grants. In 2024 alone, the filings show no purchases and 1 sale.
Most recently, on 17 May 2024, the filings show an open-market sale worth €9,467 in Gritstone bio, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Karin Jooss
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
27,128 shares0Common StockSEC:0001415889-24-013655:0
40,000 shares0Common StockSEC:0001415889-24-002714:0
252,763 shares0Common StockSEC:0001567619-23-001947:0
8,650 shares0Common StockSEC:0001209191-22-036349:0
1,483 shares@ US$22.820.015% mcap100.0% of flowCommon StockSEC:0001209191-22-034551:0
27,600 shares0Common StockSEC:0001567619-22-008721:0
27,900 shares0Common StockSEC:0001567619-21-020867:0
2,681 shares0Common StockSEC:0000899243-21-022081:0
8 of 8 declarations
